StoneX Group’s Medicus Pharma MDCX Stock Holding History

StoneX Group’s Portfolio MDCX Stock Details MDCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.76K	Sell	219 -122	-36%	-$1.69K	﹤0.01%	1928
2026 Q2	$6.36K	Buy	341 +38	+13%	+$673	﹤0.01%	1398
2026 Q1	$6.96K	Buy	+303	New	+$15.8K	﹤0.01%	867

Other funds holding MDCX

Interchange Capital Partners Pittsburgh, Pennsylvania $598M AUM 31.79% 1-Year Est. Return

Sterling Investment Advisors (Pennsylvania) Berwyn, Pennsylvania $606M AUM 21.78% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $77B AUM 19.24% 1-Year Est. Return

May Hill Capital Cohasset, Massachusetts $510M AUM 23.75% 1-Year Est. Return

Wilmington Savings Fund Society Wilmington, Delaware $4.39B AUM 17.99% 1-Year Est. Return

Summit Global Investments Bountiful, Utah $2.02B AUM 17.87% 1-Year Est. Return

StoneX Group's MDCX Position: Q3 2026 in Review

StoneX Group reduced its Medicus Pharma (MDCX) stake by 36% in Q3 2026, selling an estimated $1.69K and leaving 219 shares worth $1.76K. The position accounts for ﹤0.01% of the portfolio, ranked #1928.

StoneX Group first reported a position in MDCX in Q1 2026 and has held it in 3 quarters since. The position peaked at $6.96K in Q1 2026. 7 funds tracked by Wall St. Rank hold MDCX as of Q3 2026.

StoneX Group held 219 shares of Medicus Pharma worth $1.76K as of Q3 2026.
StoneX Group sold 122 Medicus Pharma shares in Q3 2026, an estimated $1.69K.
Medicus Pharma made up ﹤0.01% of StoneX Group's portfolio in Q3 2026, its #1928 holding.
StoneX Group first reported a position in Medicus Pharma in Q1 2026 and has held it in 3 quarters since.
StoneX Group's Medicus Pharma position peaked at $6.96K in Q1 2026.
7 funds tracked by Wall St. Rank held Medicus Pharma as of Q3 2026.

Based on StoneX Group's 13F filing for Q3 2026, filed 3 Nov 2026.